Wellington Management Group LLP 13D and 13G filings for Avidity Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-10 11:23 am Sale | 2025-12-31 | 13G | Avidity Biosciences, Inc. RNA | Wellington Management Group LLP | 723,118 0.500% | -8,961,438 (-92.53%) | Filing |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | Avidity Biosciences, Inc. RNA | Wellington Management Group LLP | 9,684,556 8.100% | 2,653,607 (+37.74%) | Filing |
| 2024-11-08 1:56 pm Purchase | 2024-09-30 | 13G | Avidity Biosciences, Inc. RNA | Wellington Management Group LLP | 7,030,949 5.970% | 7,030,949 (New Position) | Filing |